搜索临床试验以:the control group
总计80197个结果
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
CardresearchMcMaster University; Eiger BioPharmaceuticals; Cytel Inc.; Fastgrants; RainWater Foundation招聘中
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation招聘中
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)主动,不招人
-
Chulalongkorn UniversityWashington University School of Medicine; Mahidol University; Ramathibodi Hospital; Rajavithi Hospital 和其他合作者完全的
-
Enzyvant Therapeutics GmBHNational Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National... 和其他合作者批准上市
-
Sanofi终止
-
Iuliu Hatieganu University of Medicine and PharmacyProf. Dr. I. Chiricuta Institute of Oncology完全的
-
Pearl Therapeutics, Inc.完全的慢性阻塞性肺疾病美国, 德国, 英国, 中国, 台湾, 大韩民国, 日本, 捷克语, 匈牙利, 波兰, 俄罗斯联邦
-
Hospital for Special Surgery, New York完全的
-
St. Olavs HospitalNorwegian University of Science and Technology; Norwegian Air Ambulance Foundation完全的
-
University of FloridaNational Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS)完全的
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness Network, Canada完全的
-
University of South FloridaNational Cancer Institute (NCI)终止
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 缓解期成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
MedSIRStemline Therapeutics, Inc.尚未招聘晚期乳腺癌 | ER阳性乳腺癌 | HER2 阴性乳腺癌 | ESR1基因突变
-
Poznan University of Medical Sciences招聘中